Caspase-3 cleaves CYLD to restrict interferon signaling during mitochondrial apoptosis
- EMBO Rep. 2026 Jul 15. doi: 10.1038/s44319-026-00876-4.
- 1. Team SOAP, CRCI²NA, INSERM, CNRS, Université de Nantes, Nantes, France.
- 2. Equipe Labellisée Ligue Contre le Cancer, Paris, France.
- 3. Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS UMR5535, Montpellier, France.
- 4. Department of Biochemistry, University of Oxford, Oxford, UK.
- 5. Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.
- 6. Team SOAP, CRCI²NA, INSERM, CNRS, Université de Nantes, Nantes, France. [email protected].
- 7. Equipe Labellisée Ligue Contre le Cancer, Paris, France. [email protected].
Mitochondrial outer membrane permeabilization is a pivotal event in programmed cell death by Apoptosis, leading to the activation of the cysteine protease Caspase-3 (CASP3) and the release of mitochondrial nucleic acids. This release triggers the activation of the Interferon Regulatory Factor 3 (IRF3) transcription factor and the subsequent IRF3-mediated type I interferon production and cell death. CASP3 ensures Apoptosis remains immunologically silent, though the mechanisms are unclear. We report that CASP3 cleaves CYLD, a deubiquitinating enzyme crucial for cell fate and inflammatory signaling. This proteolysis occurs at a site distinct from the previously reported CASP8 site, which is involved in limiting Cell Lysis and inflammation during extrinsic Apoptosis. Although cleaved CYLD retains its enzymatic activity in vitro, knocked-in cells expressing CASP3-resistant CYLD show increased interferon signaling and enhanced cell death. Thus, a proteolytic code regulates CYLD to balance inflammation during programmed cell death.